Hilo By Aktiia
Neuchâtel, Neuchâtel, Switzerland
Company & Role Overview
High blood pressure is the world's most common disease and causes 18M deaths/year. At Hilo by Aktiia, we believe the key to improving cardiovascular health is to provide patients and physicians with a deeper understanding of the blood pressure pattern. Before Hilo, it was not possible to monitor cardiovascular health at scale.
We are a venture-backed start-up that has raised over $96M from top-tier investors in Europe and the United States. We have developed and brought to market the world's first continuous blood pressure monitor. Our technology is based on 18 years of research by our founders at the prestigious Swiss Center for Electronics and Microtechnology (CSEM). Hilo by Aktiia's solution has been validated through extensive clinical trials and received a CE Mark as a Class IIa medical device under MDR leading to commercial access of approximately 43 countries worldwide.
The VP of Software Engineering is responsible for all...
